
ããªã³ãç¯ããªã³ãç¯ç å€ã®èšºæã®åºæ¬çèãæ¹ïŒïŒïŒæ€äœåŠç
ãªã³ãç¯ã®ç
ç蚺æã®äœæ³ã«ã€ããŠ
以äžã®é
ç®ã«æ²¿ã£ãŠç·è«ã瀺ã
ãå 容ã
ïŒïŒïŒæ€äœåŠç ðä»åã¯ã³ã³
ïŒïŒïŒãªã³ãç¯ã®æ£åžžæ§é
ïŒïŒïŒèšºæã¢ã«ãŽãªãºã ã®æŠç¥
ïŒïŒïŒæ€äœåŠç
ãªã³ãç¯ã«çããç å€ã®éå¥èšºæã念é ã«åŠçãããäž»ããéå¥èšºæã¯ãæªæ§ãªã³ãè «ãçã®è»¢ç§»ãåå¿æ§ãªã³ãç¯è «å€§ã§ããããåå¿æ§ã®äžã«ã¯ãææçããå«ãŸããã®ã§ãèšåºæ å ±ã«ããããå¿ èŠã«å¿ã㊠N95ãã¹ã¯ãªã©ææå¯Ÿçãè¡ããèšåºçã«äœãçãããŠããã®ãããšããã®ã¯éåžžã«éèŠã§ããã®ã§ãå¿ ã確èªããã
ãŸããéçæ€ã FNA ã§ã®èšºæã¯é£ããããšãå€ãã®ã§ã宿œããå Žåã«ã¯èšºæã«éçãããããšãååã«èšåºå»ã«çè§£ããŠããã ãå¿ èŠãããããããèšåºå»ãçè§£ããŠããªãå Žåã蚺æã®ã€ããªãäŸµè¥²çææãäœåºŠãæ£è ã«èª²ãããšã«ãªãåŸãã®ã§æ³šæãå¿ èŠã§ãããåºæ¬ã¯è «å€§ãªã³ãç¯ããŸãããšïŒåïŒãŸãã¯ãã以äžïŒæåºããŠãããã®ãæãŸããã
æåºãããçã®ãªã³ãç¯ïŒåãåå²ãããããªãã®å€§ããã®å Žå㯠5 mm å¹ ãããã«é©å®åå²ãããæ¬¡ã«å²é¢ããæºå°çްè蚺ãäœè£œããç å€ã®éå¥èšºæãçµã£ãŠããã®ãæãŸããã
ç¹ã«ææçãçãããå ŽåãŸãã¯é€å€ã§ããªãå Žåã«ã¯å¹é€ã PCR ãªã©èåŠçæ€æ»ãè¡ãå¿ èŠããããç¹ã«çµæ žãããã¯éå®åæé žèçãçãããå Žåã«ã¯ãç çéšéã®ææå¯Ÿçããã³æ£è ã®æ²»çæ¹éã«ãããŠéèŠã§ããã
åå¿æ§ããã³æªæ§ãªã³ãè «ã«ã€ããŠããããçšåºŠçްèèšºã§æšå®å¯èœãªçäŸãããããããŒãµã€ãã¡ããªãŒïŒflow cytometryïŒFCMïŒãæè²äœæ€æ»ïŒG-BandïŒãå ç«ã°ãããªã³ãTCRïŒT-cell receptorïŒãªã©ã®éºäŒååæ§ææ€çŽ¢ïŒãµã¶ã³ããããæ³ïŒçšã®åçµæ€äœãªã©ã確ä¿ããŠããå¿ èŠããããããããçµç¹èšºæã«å·®ãæ¯ããªãç¯å²ã§ãååéæ¡åããã®ãæãŸããã
æ€äœã®åãåãã®äŸ
ïŒçäŸããšã«èããïŒ
è ¹è å ãªã³ãç¯ã®å Žåãªã©ãå šèº«éº»é äžã§è ¹è é¡ã§çæ€ãããããšãããããã®å Žåãç å€ãæ¡åãããŠãããã確èªããããã«è¿ éåçµçµç¹èšºæãå¿ èŠãªããšãããããã®éã«ããæçµèšºæã«æ¯éã®ãªãããã«è¿ é蚺æçšã®åãåããæœè¡ããªããã°ãªããªããå¿ èŠã§ããã°ãæ€äœãããå€ãæ¡åããŠãããããå€ç§å»ã«äŸé Œããã¹ãã§ãããå šèº«éº»é ãŸã§ãããŠèšºæãã€ããªãããšããããšãæãé¿ããªããã°ãªããªããæ£è ã®è² æ ãèããã°ãããæ£ç¢ºæ§ãæãå¿ èŠãããã®ã§ãã§ããã°è¿ éã§çްè蚺ã䜵çšãã¹ãã§ãããã
å²é¢ããã³çްè蚺æèŠããã®ç 倿šå®
ðæªæ§ãªã³ãè «ã®å Žå
ãªã³ãç¯ã®äžã§çްèã墿®ãããã³ãã³ã«ãç·å¯ã»ç·æºåããŠããã®ã§ãå²é¢ãèšï§ããŠããããããŠè»ããããçã ãããè²èª¿ã¯åäžã§èæ§ãä¹³çœè²èª¿ãããããã髿§ããªæãããããæºå°ãããšãããã现èãã¬ã©ã¹ã«ãã£ã€ããç¹ã«æºå°éšã®çãäžã«çްèãå€ãã€ãã®ãç¹åŸŽã§ãããåå¿æ§ã§ã¯èŸºçžã«çްèããã£ã€ããçãäžãæããããšãå€ããæŠããšãã¶ã©ããšçްèãããããåããã
现è蚺ã§ã¯ãæãããªç°åãªã³ãçæ§çŽ°èã倿°ããã°æªæ§ãšããããäžè¬ã«æ žã®ãããã»ãã³ãã匷ããš T 现èç³»ïŒATLL ã® flower cell çãªïŒãšèšãããããå人çã«ã¯ãããŸã§ç°¡åã«èšããªãããšãå€ããšããå°è±¡ã§ãããç°åã¯ããã»ã©ãªããŠããåäžãªçްèãäžæ§ã«ã¿ãããå Žåã«ã¯ low-grade B-cell lymphoma ãå€ãããããã¯åå¿æ§ãšã®åºå¥ãé£ããïŒãã®å Žåãšãã«çµç¹ãé£ããã®ã§ãFCM ãéèŠã§ããïŒããŸããæºå°ã§æ¿Ÿèæ§ã«çµç¯ç¶æ§é ãåããŠãããšæ¿Ÿèæ§ãªã³ãè «ã®å¯èœæ§ããããããžãã³ãªã³ãè «ã¯ãçµç¹æèŠãšåãããã«ãHodgkin-Reed-SternbergïŒHRSïŒçްèã«å ããŠãç¹åŸŽçãªèæ¯æèŠãããã°ããããããããHRS æ§çްè㯠DLBCL ã§ãåºçŸãåŸãããå ç«äžå šç¶æ ã§ã®ãªã³ã墿®æ§çŸæ£ãªã©ã¯ç¹ã« HRS æ§ã® EBV éœæ§çްèã䌎ã£ãŠããžãã³æ§ã®æèŠã瀺ãã®ã§ãæ£è èæ¯ãéèŠã§ããã
ðçã®è»¢ç§»ã®å Žå
ãªã³ãç¯å šäœã«è»¢ç§»ãããã°ãèçŒäžããªã³ãç¯ã¯éåžžã«ç¡¬ãããšãå€ããã壿»ãããã¯è§åãªã©ãåããå Žåãããã现è蚺ã§ãè¿ éçµç¹èšºã§ãé£ãããªãããšãå€ããããALCL ãªã©ã§ã¯äžèŠçµç¹åã¯çè «æ§ã«ãªãã®ã§ãè¿ éã§ã®åºå¥ããã°ãã°é£ããã现èèšºã®æ¹ãæçšãããããªãããŸãããªã³ãç¯ã®äžéšã®ã¿ã«çã®è»¢ç§»ãããå Žåãè¿ éçµç¹èšºã§ã¯åå¿æ§ã low-grade B ãé£ãããšæãããçäŸã§ã现è蚺ã§çãåºçŸããŠããçäŸãçµéšããŠããã
ðåå¿æ§ç å€ã®å Žå
å€ãã¯é£ããããèèœè «æ§çŸæ£ããããå Žåããããçµæ žãªã©ã§å£æ»ãããå Žåã«ã¯ãèçŒã§ããããããšããèŠãç®ã§ãæŒãã€ã¶ããšã ãã¥ïœã£ãŠæãã§æ±ã滲ã¿åºããé»çœè²èª¿ã®æ±ã壿»ãã¿ãããã壿»ãããªãåªå¢ãªå Žåã¯ãããããè¶ ããŠãå šäœãã¯ãªãŒã ç¶ã«ããããšããŠããããããªããšå€§å€ã§ãããããç°å¢ãæŽã£ãŠããªããã°ãå¯åçéããã«ãN95 ãã¹ã¯ççšãšé©åãªææ°ããæºåãããè¯ãïŒãã¡ãããã¯ããããããããç°å¢ã§ããããšãäžçªæãŸããïŒãè¿ éçµç¹ã¯çŠå¿ã§ãããèåéçšã§èã空æ°äžã«é£ã³æ£ãããã ãç å€ã®æ§ç¶ãæ°ã«ãªããªãã°ãæºå°çްè蚺ãäœè£œããé¡äžç®çްèèèœè «ãªã©ãæ¢ãã®ãããã絶察ã«å¿ èŠãªã®ã¯ãå¹é€ãã§ãããçŽ°èæ€æ»ã«æåºããªããã°ãªããªããçèææãªã©ä»ã®éå¥èšºæãæããããçµæãããããŸã§ã¯çµæ žã®å¯èœæ§ããããã®ãšããŠå¯ŸåŠãããè¯ãããã®ä»ã®äžè¬çãªåå¿æ§ç å€ã®éå¥ã¯èçŒã现è蚺ãè¿ éçµç¹èšºæã§ã¯å°é£ã§ããããšãå€ãã
ãªã³ãé è¡åšç³»ã®ç®æ¬¡ã¯ãã¡ãð
ãç çå»ãã®ãŒãšãã¡ãã¥ãŒ
ðãç çå»ãã®ãŒãšãã®èªå·±ç޹ä»
ðãç çå»ãã®ãŒãšãã®ãµã€ãããã
ðãSANOTIC ARCHIVESãå»çç³»ãµã€ãããã
 #ç çå»ãã®ãŒãš #ç ç蚺æ #ç çåŠ #å»åŠ #å»ç #æªæ§ãªã³ãè « #ãªã³ãç¯ #现è蚺 #çµæ ž #è¿ é蚺æ
